1
|
Borrego-Écija S, Cortés-Vicente E, Cervera-Carles L, Clarimón J, Gámez J, Batlle J, Ricken G, Molina-Porcel L, Aldecoa I, Sánchez-Valle R, Rojas-García R, Gelpi E. Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases. Neuropathol Appl Neurobiol 2018; 45:421-426. [PMID: 30375034 PMCID: PMC7380051 DOI: 10.1111/nan.12527] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 10/10/2018] [Indexed: 01/29/2023]
Affiliation(s)
- S Borrego-Écija
- Neurology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.,Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain
| | - E Cortés-Vicente
- Neurology Department, Institut d'Investigacions Biomèdiques-Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - L Cervera-Carles
- Neurology Department, Institut d'Investigacions Biomèdiques-Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.,Center for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - J Clarimón
- Neurology Department, Institut d'Investigacions Biomèdiques-Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.,Center for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - J Gámez
- Neurology Department, Hospital de la Vall d'Hebron, Barcelona, Spain
| | - J Batlle
- Neurology Department, Hospital Sant Pau y Santa Tecla, Tarragona, Spain
| | - G Ricken
- Institute of Neurology, Medical University of Vienna, Vienna, Austria
| | - L Molina-Porcel
- Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain
| | - I Aldecoa
- Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain.,Pathology Department, CDB, Hospital Clinic Barcelona, Barcelona, Spain
| | - R Sánchez-Valle
- Neurology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.,Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain
| | - R Rojas-García
- Neurology Department, Institut d'Investigacions Biomèdiques-Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.,Center for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED), Madrid, Spain
| | - E Gelpi
- Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain.,Institute of Neurology, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
2
|
Alonso‐Jiménez A, Ramón C, Dols‐Icardo O, Roig C, Gallardo E, Clarimón J, Núñez‐Peralta C, Díaz‐Manera J. Corpus callosum agenesis, myopathy and pinpoint pupils: consider Stormorken syndrome. Eur J Neurol 2018; 25:e25-e26. [DOI: 10.1111/ene.13545] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2017] [Accepted: 11/27/2017] [Indexed: 02/06/2023]
Affiliation(s)
- A. Alonso‐Jiménez
- Neuromuscular Disorders Unit Neurology Department Hospital de la Santa Creu I Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
| | - C. Ramón
- Neurology Department Hospital Universitario Central de Asturias Oviedo Spain
| | - O. Dols‐Icardo
- Memory Unit Neurology Department and Sant Pau Biomedical Research Institute Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Madrid Spain
| | - C. Roig
- Neuromuscular Disorders Unit Neurology Department Hospital de la Santa Creu I Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
| | - E. Gallardo
- Neuromuscular Disorders Unit Neurology Department Hospital de la Santa Creu I Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
- Centro de Investigación Básica en Red en Enfermedades Raras (CIBERER) Madrid Spain
| | - J. Clarimón
- Memory Unit Neurology Department and Sant Pau Biomedical Research Institute Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Madrid Spain
| | - C. Núñez‐Peralta
- Radiology Department Hospital de la Santa Creu i Sant Pau Barcelona Spain
| | - J. Díaz‐Manera
- Neuromuscular Disorders Unit Neurology Department Hospital de la Santa Creu I Sant Pau Universitat Autònoma de Barcelona Barcelona Spain
- Centro de Investigación Básica en Red en Enfermedades Raras (CIBERER) Madrid Spain
| |
Collapse
|
3
|
Compta Y, Ramos-Campoy O, Grau-Rivera O, Colom-Cadena M, Clarimón J, Martí MJ, Gelpi E. Conjoint FTLD-FUS of the neuronal intermediate filament inclusion disease type, progressive supranuclear palsy and Alzheimer's pathology presenting as parkinsonism with early falls and late hallucinations, psychosis and dementia. Neuropathol Appl Neurobiol 2017; 43:352-357. [DOI: 10.1111/nan.12340] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2015] [Revised: 08/01/2016] [Accepted: 08/04/2016] [Indexed: 11/26/2022]
Affiliation(s)
- Y. Compta
- Parkinson's Disease & Movement Disorders Unit; Neurology Service; ICN; Hospital Clínic; University of Barcelona; IDIBAPS; Barcelona Catalonia Spain
| | - O. Ramos-Campoy
- Parkinson's Disease & Movement Disorders Unit; Neurology Service; ICN; Hospital Clínic; University of Barcelona; IDIBAPS; Barcelona Catalonia Spain
- Neurological Tissue Bank; Biobanc Hospital Clínic-IDIBAPS; Barcelona Catalonia Spain
| | - O. Grau-Rivera
- Neurological Tissue Bank; Biobanc Hospital Clínic-IDIBAPS; Barcelona Catalonia Spain
| | - M. Colom-Cadena
- Neurology Department; Institut d'Investigacions Biomèdiques Sant Pau; Hospital de Sant Pau; Universitat Autònoma de Barcelona; Barcelona Catalonia Spain
| | - J. Clarimón
- Neurology Department; Institut d'Investigacions Biomèdiques Sant Pau; Hospital de Sant Pau; Universitat Autònoma de Barcelona; Barcelona Catalonia Spain
| | - M. J. Martí
- Parkinson's Disease & Movement Disorders Unit; Neurology Service; ICN; Hospital Clínic; University of Barcelona; IDIBAPS; Barcelona Catalonia Spain
| | - E. Gelpi
- Neurological Tissue Bank; Biobanc Hospital Clínic-IDIBAPS; Barcelona Catalonia Spain
| |
Collapse
|
4
|
Pardo J, Pardo-Parrado M, Clarimón J, García-Redondo A, Cebrián E, Jiménez-Martínez I, Cortés J, Aguiar P, Castiñeiras J, García-Sobrino T, Quintáns B, Sobrido M. Clinical and neuroimaging features of familial C9FTD/ALS: A case report. J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.1597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
5
|
Díaz-Manera J, Querol L, Clarimón J, Yagüe S, Illa I. Unique post-exercise electrophysiological test results in a new Andersen–Tawil syndrome mutation. Clin Neurophysiol 2011; 122:2537-9. [DOI: 10.1016/j.clinph.2011.04.025] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2011] [Revised: 04/19/2011] [Accepted: 04/19/2011] [Indexed: 10/18/2022]
|
6
|
Fortea J, Lladó A, Clarimón J, Lleó A, Oliva R, Peri J, Pintor L, Yagüe J, Blesa R, Molinuevo J, Sánchez-Valle R. PICOGEN: Five years experience with a genetic counselling program for dementia. Neurología (English Edition) 2011. [DOI: 10.1016/s2173-5808(11)70030-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Open
|
7
|
Coma M, Serenó L, Da Rocha-Souto B, Scotton TC, España J, Sánchez MB, Rodríguez M, Agulló J, Guardia-Laguarta C, Garcia-Alloza M, Borrelli LA, Clarimón J, Lleó A, Bacskai BJ, Saura CA, Hyman BT, Gómez-Isla T. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2010; 38:482-91. [PMID: 20149872 DOI: 10.1016/j.nbd.2010.01.019] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2009] [Revised: 12/04/2009] [Accepted: 01/27/2010] [Indexed: 12/30/2022] Open
Abstract
Inflammation has been associated with the two classic lesions in the Alzheimer's (AD) brain, amyloid deposits and neurofibrillary tangles. Recent data suggest that Triflusal, a compound with potent anti-inflammatory effects in the central nervous system in vivo, might delay the conversion from amnestic mild cognitive impairment to a fully established clinical picture of dementia. In the present study, we investigated the effect of Triflusal on brain Abeta accumulation, neuroinflammation, axonal curvature and cognition in an AD transgenic mouse model (Tg2576). Triflusal treatment did not alter the total brain Abeta accumulation but significantly reduced dense-cored plaque load and associated glial cell proliferation, proinflammatory cytokine levels and abnormal axonal curvature, and rescued cognitive deficits in Tg2576 mice. Behavioral benefit was found to involve increased expression of c-fos and BDNF, two of the genes regulated by CREB, as part of the signal transduction cascade underlying the molecular basis of long-term potentiation. These results add preclinical evidence of a potentially beneficial effect of Triflusal in AD.
Collapse
Affiliation(s)
- M Coma
- Neurology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Serenó L, Coma M, Rodríguez M, Sánchez-Ferrer P, Sánchez MB, Gich I, Agulló JM, Pérez M, Avila J, Guardia-Laguarta C, Clarimón J, Lleó A, Gómez-Isla T. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis 2009; 35:359-67. [PMID: 19523516 DOI: 10.1016/j.nbd.2009.05.025] [Citation(s) in RCA: 246] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2009] [Revised: 05/18/2009] [Accepted: 05/28/2009] [Indexed: 01/22/2023] Open
Abstract
Amyloid deposits, neurofibrillary tangles, and neuronal cell death in selectively vulnerable brain regions are the chief hallmarks in Alzheimer's (AD) brains. Glycogen synthase kinase-3 (GSK-3) is one of the key kinases required for AD-type abnormal hyperphosphorylation of tau, which is believed to be a critical event in neurofibrillary tangle formation. GSK-3 has also been recently implicated in amyloid precursor protein (APP) processing/Abeta production, apoptotic cell death, and learning and memory. Thus, GSK-3 inhibition represents a very attractive drug target in AD and other neurodegenerative disorders. To investigate whether GSK-3 inhibition can reduce amyloid and tau pathologies, neuronal cell death and memory deficits in vivo, double transgenic mice coexpressing human mutant APP and tau were treated with a novel non-ATP competitive GSK-3beta inhibitor, NP12. Treatment with this thiadiazolidinone compound resulted in lower levels of tau phosphorylation, decreased amyloid deposition and plaque-associated astrocytic proliferation, protection of neurons in the entorhinal cortex and CA1 hippocampal subfield against cell death, and prevention of memory deficits in this transgenic mouse model. These results show that this novel GSK-3 inhibitor has a dual impact on amyloid and tau alterations and, perhaps even more important, on neuronal survival in vivo further suggesting that GSK-3 is a relevant therapeutic target in AD.
Collapse
Affiliation(s)
- L Serenó
- Departamento de Neurología, Hospital Santa Cruz y San Pablo, Universidad Autónoma de Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Clarimón J, Djaldetti R, Lleó A, Guerreiro RJ, Molinuevo JL, Paisán-Ruiz C, Gómez-Isla T, Blesa R, Singleton A, Hardy J. Whole genome analysis in a consanguineous family with early onset Alzheimer's disease. Neurobiol Aging 2008; 30:1986-91. [PMID: 18387709 DOI: 10.1016/j.neurobiolaging.2008.02.008] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2007] [Revised: 02/12/2008] [Accepted: 02/14/2008] [Indexed: 01/09/2023]
Abstract
Early-onset Alzheimer's disease (EOAD) is a clinically and genetically heterogeneous condition in which the typical features appear significantly earlier in life (before 65 years). Mutations in three genes (PSEN1, PSEN2, and APP) have been identified in autosomal dominant forms of EOAD. However, in about 50% of Mendelian cases and in most of the sporadic EOAD patients, no mutations have been found. We present clinical characteristics of an Israeli family comprising two affected siblings with EOAD born to neurologically healthy parents who were first cousins (both parents died after 90 years old). Sequence analysis of PSEN1, PSEN2, APP, TAU, PGRN, and PRNP failed to reveal any mutations in the affected siblings. Because the disease in this family is consistent with an autosomal recessive mode of inheritance we identified all homozygous regions identical by descent (IBD) in both siblings, by high-density SNP genotyping. We provide here the first catalog of autozygosity in EOAD and suggest that the regions identified are excellent candidate loci for a recessive genetic lesion causing this disease.
Collapse
Affiliation(s)
- J Clarimón
- Memory Unit, Alzheimer's Laboratory, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Clarimón J, Muñoz FJ, Boada M, Tàrraga L, Sunyer J, Bertranpetit J, Comas D. Possible increased risk for Alzheimer's disease associated with neprilysin gene. J Neural Transm (Vienna) 2003; 110:651-7. [PMID: 12768360 DOI: 10.1007/s00702-002-0807-3] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Neprilysin has recently been reported to be the major physiological Abeta-degradating enzyme. In this study we describe a new biallelic polymorphism in the 3'UTR of the neprilysin gene in a representative population sample. The (*)159C/C genotype was found to be associated with an increased risk for Alzheimer's disease in an age-dependent manner. Adjusting for sex and APOE status, an odds ratio of 2.74 (p < 0.05) was observed among patients under 75 years old.
Collapse
Affiliation(s)
- J Clarimón
- Unitat de Biologia Evolutiva, Universitat Pompeu Fabra, Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
11
|
Pérez-Lezaun A, Calafell F, Clarimón J, Bosch E, Mateu E, Gusmão L, Amorim A, Benchemsi N, Bertranpetit J. Allele frequencies of 13 short tandem repeats in population samples from the Iberian Peninsula and northern Africa. Int J Legal Med 2001; 113:208-14. [PMID: 10929236 DOI: 10.1007/s004149900091] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The 13 short tandem repeat (STR) loci D3S1358, vWA, FGA, D16S539, TH01, TPOX, CSF1PO, D8S1179, D21S11, D18S51, D5S818, D13S317 and D7S820 as well as the amelogenin locus, contained in AmpFlSTR Profiler Plus and/or AmpFlSTR Cofiler and/or AmpFlSTR Green I PCR amplification kits, were studied in four populations from the Iberian Peninsula, Basques, Catalans, Andalusians and Portuguese and two North African populations (Moroccan Arabs and Berbers). The aim of the study was to obtain accurate allele frequency data and other genetic parameters of forensic interest on the main representative human groups living in Iberia and Morocco using an automated method and commercial amplification kits.
Collapse
Affiliation(s)
- A Pérez-Lezaun
- Unitat de Biologia Evolutiva, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Affiliation(s)
- E Bosch
- Unitat de Biologia Evolutiva, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, 08003 Barcelona, Spain
| | | | | | | |
Collapse
|
13
|
Bosch E, Calafell F, Pérez-Lezaun A, Clarimón J, Comas D, Mateu E, Martínez-Arias R, Morera B, Brakez Z, Akhayat O, Sefiani A, Hariti G, Cambon-Thomsen A, Bertranpetit J. Genetic structure of north-west Africa revealed by STR analysis. Eur J Hum Genet 2000; 8:360-6. [PMID: 10854096 DOI: 10.1038/sj.ejhg.5200464] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
We have analysed a large set of autosomal short tandem repeat (STR) loci in several Arabic and Berber-speaking groups from north-west Africa (ie Moroccan Arabs, northern-central and southern Moroccan Berbers, Saharawis, and Mozabites). Two levels of analysis have been devised using two sets of 12STR loci, (D3S1358, vWA, FGA, THO1, TPOX, CSF1PO, D8S1179, D21S11, D18S51, D5S818, D13S317 and D7S820) and 21 (the former set plus D9S926, D11S2010, D13S767, D14S306, D18S848, D2S1328, D4S243, F13A1, and FES/FPS). For each set, data for a number of external reference populations were gathered from the literature. Several methods of analysis based on genetic distances (neighbour-joining trees, principal coordinate analysis, boundary detection), as well as AMOVA, showed that genetic differentiation among NW African populations was very low and devoid of any spatial pattern. When the NW African populations were grouped according to cultural or linguistic differences, the partition was not associated with genetic differentiation. Thus, it is likely that Arabisation was mainly a cultural process. A clear genetic difference was found between NW African populations and Iberians, which underscores the Gilbraltar Straits as a strong barrier to genetic exchange; nonetheless, some degree of gene flow into Southern Iberia may have existed. NW Africans were genetically closer to Iberians and to other Europeans than to African Americans.
Collapse
Affiliation(s)
- E Bosch
- Unitat de Biologia Evolutiva, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Pérez-Lezaun A, Calafell F, Comas D, Mateu E, Bosch E, Martínez-Arias R, Clarimón J, Fiori G, Luiselli D, Facchini F, Pettener D, Bertranpetit J. Sex-specific migration patterns in Central Asian populations, revealed by analysis of Y-chromosome short tandem repeats and mtDNA. Am J Hum Genet 1999; 65:208-19. [PMID: 10364534 PMCID: PMC1378092 DOI: 10.1086/302451] [Citation(s) in RCA: 94] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Eight Y-linked short-tandem-repeat polymorphisms (DYS19, DYS388, DYS389I, DYS389II, DYS390, DYS391, DYS392, and DYS393) were analyzed in four populations of Central Asia, comprising two lowland samples-Uighurs and lowland Kirghiz-and two highland samples-namely, the Kazakhs (altitude 2,500 m above sea level) and highland Kirghiz (altitude 3,200 m above sea level). The results were compared with mtDNA sequence data on the same individuals, to study possible differences in male versus female genetic-variation patterns in these Central Asian populations. Analysis of molecular variance (AMOVA) showed a very high degree of genetic differentiation among the populations tested, in discordance with the results obtained with mtDNA sequences, which showed high homogeneity. Moreover, a dramatic reduction of the haplotype genetic diversity was observed in the villages at high altitude, especially in the highland Kirghiz, when compared with the villages at low altitude, which suggests a male founder effect in the settlement of high-altitude lands. Nonetheless, mtDNA genetic diversity in these highland populations is equivalent to that in the lowland populations. The present results suggest a very different migration pattern in males versus females, in an extended historical frame, with a higher migration rate for females.
Collapse
Affiliation(s)
- A Pérez-Lezaun
- Unitat de Biologia Evolutiva, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|